Cole Steber, MD
Radiation Oncology · Athens, GANPI 1952836967
Payments from drug & device makers
Across 75 payments — averaging $21.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$201
- Sobi, Inc$111
- Novocure Inc.$106
- Regeneron Healthcare Solutions, Inc.$104
- Merck$83
- Sumitomo Pharma America, Inc.$80
- plus $956 from 34 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 9 | $201 |
| Sobi, Inc | 5 | $111 |
| Novocure Inc. | 2 | $106 |
| Regeneron Healthcare Solutions, Inc. | 5 | $104 |
| Merck | 3 | $83 |
| Sumitomo Pharma America, Inc. | 4 | $80 |
| Daiichi Sankyo Inc. | 4 | $72 |
| Pfizer | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Gilead | 2 | $41 |
| Genentech USA, Inc. | 2 | $41 |
| Boston Scientific | 2 | $40 |
| Bayer | 2 | $39 |
| Organogenesis Inc. | 1 | $37 |
| Teleflex LLC | 1 | $35 |
| Kyowa Kirin, Inc. | 2 | $34 |
| Spectrum Pharmaceuticals Inc. | 2 | $34 |
| Eisai Inc. | 2 | $33 |
| Genmab U.S., Inc. | 1 | $32 |
| Boehringer Ingelheim | 1 | $29 |
| Ambu Inc. | 1 | $27 |
| Cycle Pharmaceuticals Inc | 1 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Blueprint Medicines Corporation | 1 | $23 |
| Hologic Sales And Service, LLC | 1 | $22 |
| Avyxa Pharma, LLC | 1 | $20 |
| AVEO Pharmaceuticals, Inc. | 1 | $20 |
| Cumberland Pharmaceuticals, Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
| Recordati_rare_diseases_inc. | 1 | $18 |
| Beigene USA, Inc. | 1 | $18 |
| Agios Pharmaceuticals, Inc. | 1 | $18 |
| EMD Serono, Inc. | 1 | $18 |
| Geron Corporation | 1 | $18 |
| Karyopharm Therapeutics Inc. | 1 | $17 |
| ADC Therapeutics America, Inc. | 1 | $15 |
| Telix Pharmaceuticals | 1 | $15 |
| Incyte Corporation | 1 | $15 |
| Exelixis Inc. | 1 | $14 |
| Bristol Myers Squibb | 1 | $14 |
How this compares
$1,641 in reported general payments places this provider in the 75th percentile of 165 radiation oncology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Athens
- Gordon SchoenfeldAthens$5K
- Kristin HigginsAtlanta$6M
- Mohammad KhanAtlanta$4.1M
- Walter CurranAtlanta$2.2M
- Sagar PatelAtlanta$964K
- Jim ZhongAtlanta$316K
- Hui-Kuo ShuAtlanta$264K
- Adam NowlanAtlanta$184K
- Feng-Ming KongAugusta$145K
- Sibo TianAtlanta$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.